#glp-1-drugs

[ follow ]
#weight-loss #novo-nordisk #telehealth #eli-lilly-competition #alcoholism #substance-use-disorders
Wellness
fromLondon On The Inside
6 days ago

Is Everyone On the Jab?

Four weekly 2.5 mg Mounjaro injections were tried after regained weight, amid widespread GLP-1 use, celebrity endorsements, and reports of micro-dosing benefits.
Agriculture
fromFortune
1 week ago

Billionaire beef boss says Americans crave so much protein the country is outpacing its own production and turning to imports | Fortune

U.S. beef demand exceeds domestic production, driving record prices and increased reliance on imports.
fromwww.theguardian.com
3 weeks ago

The Thin Duck: Heston Blumenthal's new menu for diners on weight-loss jabs

What struck me was the feeling of not being hungry, he tells the Guardian. I still wanted to eat, but I didn't feel that drive. It made me think this is going to kill the restaurant industry, because if people aren't eating as much, restaurants won't be as enticing. I'm not sure what will happen to supermarkets either. I don't think this change is bad for health.
Food & drink
Business
fromFuturism
1 month ago

The Inventor of Ozempic Is Suddenly Sacking Huge Numbers of Employees

Novo Nordisk will cut about 11% of its workforce (roughly 9,000 employees) to save $1.3 billion amid shrinking GLP-1 market share and intensified competition.
#novo-nordisk
more#novo-nordisk
Food & drink
fromLos Angeles Times
1 month ago

Column: Tailgating will be the battlefield for GLP-1s vs. snack companies

GLP-1 drug use is shifting American tailgating and grocery habits toward lower-calorie, less ultra-processed foods, prompting retail reformulation despite high obesity rates.
#alcoholism
more#alcoholism
#healthcare
fromFortune
1 month ago
Healthcare

How GoodRx CEO Wendy Barnes is trying to halve the cost of GLP-1 obesity drugs

fromFortune
1 month ago
Healthcare

How GoodRx CEO Wendy Barnes is trying to halve the cost of GLP-1 obesity drugs

more#healthcare
Health
fromWIRED
2 months ago

Eli Lilly's Obesity Pill Shows Promising Weight Loss in New Results

Eli Lilly's orforglipron offers an oral option with over 12% average weight loss for adults with obesity.
Health
fromNew York Post
2 months ago

Former X CEO Linda Yaccarino lands new gig at digital health firm focused on weight loss drugs

Linda Yaccarino has been appointed CEO of eMed Population Health after leaving her role at X, focusing on technology in healthcare.
#weight-loss
fromFuturism
4 months ago
Alternative medicine

This Sleazy GLP-1 Prescription Site Is Using Deepfaked "Before-and-After" Photos of Fake Patients, and Running Ads Showing AI-Generated Ozempic Boxes

Wine
fromNew York Post
5 months ago

How much less Irish people drank while taking weight loss drugs like Ozempic: study

GLP-1 drugs like Ozempic aid weight loss and notably reduce alcohol consumption among users.
Wearables
fromwww.nytimes.com
5 months ago

How Ozempic is Shaping Weddings

Weight-loss medications like Zepbound are reshaping the wedding industry and conversations around body image, particularly for brides.
Alternative medicine
fromFuturism
4 months ago

This Sleazy GLP-1 Prescription Site Is Using Deepfaked "Before-and-After" Photos of Fake Patients, and Running Ads Showing AI-Generated Ozempic Boxes

MEDVi's marketing for GLP-1 drugs heavily relies on AI-generated images and fabricated testimonials, raising ethical concerns in patient health advertising.
more#weight-loss
#telehealth
fromAxios
2 months ago
Digital life

Former X CEO Linda Yaccarino named CEO of telehealth weight-loss drug company

fromWIRED
5 months ago
Alternative medicine

Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

fromAxios
2 months ago
Digital life

Former X CEO Linda Yaccarino named CEO of telehealth weight-loss drug company

fromWIRED
5 months ago
Alternative medicine

Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

more#telehealth
Health
fromwww.cnbc.com
2 months ago

Former X CEO Linda Yaccarino takes helm at digital health company eMed

Linda Yaccarino has been appointed CEO of eMed Population Health, focusing on GLP-1 population health management.
Public health
fromFuturism
2 months ago

Doctors Say Ozempic Is Wildly Effective at Helping Addicts Beat Cravings

GLP-1 drugs like Ozempic and Wegovy show promise as treatments for various addictions, gaining attention for their off-label use in rehabilitation settings.
fromBoston.com
2 months ago

America's protein obsession is transforming the dairy industry

"We ought to be thanking people who are buying whey protein at Aldi's," said Heiman, who, in addition to being a Master Cheesemaker, is Nasonville's CEO. "It definitely enhances the bottom line."
US news
Healthcare
fromInsideHook
3 months ago

Chinese Companies Are Developing Advanced GLP-1 Drugs

International collaboration is crucial in the research and development of new pharmaceuticals, particularly for diabetes and weight loss treatments.
Health
fromInsideHook
3 months ago

Compounding Breaks Up Novo Nordisk-Hims & Hers Partnership

Compounded alternatives to GLP-1 drugs raise safety concerns and regulatory scrutiny.
#obesity
fromwww.npr.org
3 months ago
US news

Advice for trying GLP-1 drugs for weight loss from a doctor who's been there

Dr. Kessler emphasizes the impact of ultra-processed foods on obesity and discusses his personal journey with GLP-1 weight loss medications.
fromThe Atlantic
5 months ago
Public health

Who Should Really Be on Weight-Loss Drugs?

GLP-1 drugs should be prescribed based on a specific risk profile rather than just weight or obesity.
more#obesity
Growth hacking
fromFuturism
4 months ago

Weight Loss Influencer's Fans Angry When She Reveals How She Was Really Pulling It Off

Janelle Rohner faced backlash for not disclosing her weight loss drug use while promoting fat loss courses.
fromFast Company
4 months ago

What's actually driving the protein boom?

GLP-1 drugs like Ozempic and Wegovy are altering hunger signals in the brain, reshaping consumption patterns and redefining how we think about food.
Silicon Valley food
Social media marketing
fromDigiday
4 months ago

Danone takes cues from pharma marketing as GLP-1 changes American appetites

Food brands are responding to GLP-1 drug usage by adapting product offerings and marketing strategies.
Danone's Oikos targets health-focused consumers using a multi-channel strategy influenced by pharmaceutical marketing.
NYC startup
fromABC7 Los Angeles
5 months ago

WeightWatchers files for bankruptcy

WeightWatchers has filed for Chapter 11 bankruptcy to restructure its debt and adapt to emerging weight loss methods, ensuring continued operations for members.
Wellness
fromThe Drum
6 months ago

GLP-1 didn't just upend Weight Watchers. It's exposing a wider brand dilemma

Weight Watchers files for bankruptcy, signaling a shift in weight loss approaches due to the rise of GLP-1 drugs.
[ Load more ]